Classes
Publications
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Monoclonal antibodies in the treatment of dyslipidemia and cardiovascular risk lowering2016 | First Faculty of Medicine
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy2015 | First Faculty of Medicine
- Plant sterols and stanols: not yet own recommendations for diet enrichment targeted reduction of LDL - cholesterol and cardiovascular risk2015 | First Faculty of Medicine
- Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: Data from the MedPed CZ database and the Czech population2011 | First Faculty of Medicine
- Dyslipidemia and obesity 2011. How are related and what is different2011 | First Faculty of Medicine
- Interaction of common sequence variants and selected risk factors in determination of HDL cholesterol levels.2010 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipoproteinaemia 1. Classification, diagnostics, cardiovascular, cardiometabolic, residual risk2010 | First Faculty of Medicine
- Fibrates in the treatment of diabetic dyslipidemia2010 | First Faculty of Medicine
- Do you know how to manage patients with severe (familial) hypercholesterolemia?2010 | First Faculty of Medicine
Loading network view...